—

the type of the underlying assets and the degree of transparency of the underlying assets,

—

the degree of transparency of costs and charges associated with the insurance-based investment product, financial activity or financial practice and, in particular, the lack of transparency resulting from multiple layers of cost and charges,

—

the complexity of the performance calculation, taking into account in particular whether the return is dependent on the performance of one or more underlying assets which are in turn affected by other factors,

—

the nature and scale of any risks,

—

whether the insurance-based investment product or service is bundled with other products or services, or

—

the complexity of any terms and conditions;

—

the notional value of the insurance-based investment product,

—

the number of clients, investors or market participants involved,

—

the relative share the product in investors' portfolios,

—

the probability, scale and nature of any detriment, including the amount of loss potentially suffered,

—

the anticipated duration of the detrimental consequences,

—

the volume of the premium,

—

the number of intermediaries involved,

—

the growth of the market or sales,

—

the average amount invested by each investor in the insurance-based investment product,

—

the coverage level defined in national insurance guarantee schemes law, where such scheme exist, or

—

the value of the technical provisions with respect to the insurance-based investment products;

—

whether the investor is a retail client, professional client or eligible counterparty as defined in Directive 2014/65/EU of the European Parliament and of the Council (3),

—

features characterising investors' skills and abilities, including the level of education, experience with similar insurance-based investment products or selling practices,

—

features characterising investors' economic situation, including their income and wealth,

—

investors' core financial objectives, including pension savings and need for risk coverage,

—

whether the product or service is being sold to investors outside the intended target market, or whether the target market has not been adequately identified, or

—

the eligibility for coverage by an insurance guarantee scheme, where national insurance guarantee schemes exist;

—

the type and transparency of the underlying assets,

—

any hidden costs and charges,

—

the use of techniques drawing investors' attention but not necessarily reflecting the suitability or overall quality of the insurance-based investment product or financial activity or financial practice,

—

the nature of risks and transparency of risks,

—

the use of product names or terminology or other information that imply a greater level of security or return than those which are actually possible or likely, or which imply product features that do not exist, or

—

whether there was insufficient, or insufficiently reliable, information about an insurance-based investment product to enable market participants to which it was targeted to form their judgment, taking into account the nature and type of insurance-based investment products;

—

the leverage inherent in the product,

—

the leverage due to financing, or

—

the features of securities financing transactions;

—

the structuring cost of such insurance-based investment product, financial activity or financial practice and other costs,

—

the disparity in relation to the issuer's risk retained by the issuer, or

—

the risk/return profile;

—

the impediments to a change of investment strategy in relation to an insurance contract,

—

the fact that early withdrawal is contractually not allowed or made factually impossible, or

—

any other barriers to exit;

—

the use of hidden or secondary charges, or

—

charges that do not reflect the level of distribution service provided by the insurance intermediaries;

—

the degree of innovation related to the structure of the insurance-based investment product, financial activity or financial practice, including embedding and triggering,

—

the degree of innovation related to the distribution model or length of intermediation chain,

—

the extent of innovation diffusion, including whether the insurance-based investment product, financial activity or financial practice is innovative for particular categories of investors,

—

innovation involving leverage,

—

the lack of transparency of the underlying assets, or

—

the past experience of the market with similar insurance-based investment products or selling practices for insurance-based investment products;

—

the communication and distribution channels used,

—

the information, marketing or other promotional material associated with the investment, or

—

whether the decision to buy is secondary or tertiary following an earlier purchase;

—

the financial situation of the issuer, or

—

the suitability of reinsurance arrangements regarding the insurance-based investment products;

—

any fraud or dishonesty,

—

misconduct in, or misuse of information in relation to a financial market,

—

handling the proceeds of crime,

—

the financing of terrorism, or

—

facilitating money laundering;